Screening for human papillomavirus, cervical cytological abnormalities and associated risk factors in <scp>HIV</scp>‐positive and <scp>HIV</scp>‐negative women in Rwanda

Abstract

The currently used quadrivalent vaccine may be insufficient to give satisfactory HPV coverage in Rwanda. HPV Screening may be effective to identify women at risk of developing cervical cancer, particularly if provided to high-risk patients.